Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: A population-based case-control study

Journal of General Virology

Volumn 80, Issue 2, 1999, Pages 391-398

  Kjellberg, Lennart ^a   Wang, Zhaohui ^b   Wiklund, Fredrik ^a   Edlund, Karin ^a   Ångström, Tord ^a   Lenner, Per ^a   Sjöberg, Inga ^a   Hallmans, Göran ^a   Wallin, Keng Ling ^b   Sapp, Martin ^c   Schiller, John ^d   Wadell, Göran ^a   Mählck, Carl Gustav ^a   Dillner, Joakim ^a,b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SWEDEN; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE; TRIXIS;

EID: 0032968974     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-2-391     Document Type: Article

References (41)

1. af Geijersstam, V., Kibur, M., Wang, Z., Koskela, P., Pukkala, E., Schiller, J. T., Lehtinen, M. & Dillner, J. (1998). Stability over time of serum antibody levels to human papillomavirus type 16. Journal of Infectious Diseases 177, 1710-1714.
2. Andersson-Ellström, A., Dillner, J., Hagmar, B., Schiller, J., Sapp, M., Forssman, L. & Milsom, I. (1996). Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sexually Transmitted Diseases 23, 234-238.
3. Bauer, H. M., Ting, Y., Greer, C., Chambers, J., Tashiro, C., Chimera, J., Reingold, A. & Manos, M. M. (1991). Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265, 472-478.
4. Becker, T., Wheeler, C. M., McGough, N. S., Parmenter, C., Jordan, S. W., Stidley, C. A., McPherson, S. & Dorin, M. H. (1994). Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 271, 1181-1188.
5. Brinton, L. A., Hamman, R. F., Huggins, G. R., Lehman, H. F., Levine, R. S., Mallin, K. & Fraumeni, J. F. (1987). Sexual and reproductive risk factors for invasive squamous cell cervical cancer. Journal of the National Cancer Institute 79, 23-30.
6. Carter, J. J., Koutsky, L. A., Wipf, G. C., Christensen, N. D., Lee, S. K., Kuypers, J., Kiviat, N. & Galloway, D. A. (1996). The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. Journal of Infectious Diseases 174, 927-936.
7. Chua, K.-L., Wiklund, F., Lenner, P., Ångström, T., Hallmans, G., Bergman, F., Sapp, M., Schiller, J., Wadell, G., Hjerpe, A. & Dillner, J. (1996). A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears. International Journal of Cancer 68, 54-59.
8. de Gruijl, T. D., Bontkes, H. J., Walboomers, J. M. M., Schiller, J. T., Stukart, M. J., Groot, B. S., Chabaud, M. M., Remmink, A. J., Verheijen, R. H., Helmerhorst, T. J., Meijer, C. J. & Scheper, R. J. (1997). Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. Journal of the National Cancer Institute 89, 630-638.
9. de Sanjosé, S., Munoz, N., Bosch, F. X., Reimann, K., Pedersen, N. S., Orfila, J., Ascunce, N., González, L. C., Tafur, L., Gilli, M., Lette, I., Viladiu, P., Tormo, M. J., Moreo, P., Shah, K. & Wahren, B. (1994). Sexually transmitted agents and cervical neoplasia in Colombia and Spain. International Journal of Cancer 65, 358-363.
10. Dillner, J., Lenner, P., Lehtinen, M., Eklund, C., Heino, P., Wiklund, F., Hallmans, G. & Stendahl, U. (1994). A population-based seroepidemiological study of cervical cancer. Cancer Research 54, 134-141.
11. Dillner, J., Kallings, I., Brihmer, C., Sikström, B., Koskela, P., Lehtinen, M., Schiller, J. T., Sapp, M. & Mårdh, P. A. (1996). Seropositivity to human papillomavirus types 16, 18 or 33 capsids and to Chlamydia trachomatis are markers of sexual behaviour. Journal of Infectious Diseases 173, 1394-1398.
12. Dillner, J., Lehtinen, M., Björge, T., Luostarinen, T., Youngman, L., Jellum, E., Koskela, P., Gislefoss, R. E., Hallmans, G., Paavonen, J., Sapp, M., Schiller, J. T., Hakulinen, T., Thoresen, S. & Hakama, M. (1997). Prospective seroepidemiological study of human papillomavirus infection as risk factor for invasive cervical cancer. Journal of the National Cancer Institute 89, 1293-1299.
13. Dillner, J., Knekt, P., Boman, J., Lehtinen, M., Af Geijersstam, V., Sapp, M., Schiller, J., Maatela, J. & Aromaa, A. (1998). Seroepidemiological association between human papillomavirus infection and risk of prostate cancer. International Journal of Cancer 75, 564-567.
14. Evander, M. & Wadell, G. (1991). A general primer for amplification and detection of genital human papillomavirus types. Journal of Virological Methods 31, 239-250.
15. Evander, M., Edlund, K., Boden, E., Gustavsson, Å., Jonsson, M., Karlsson, R., Rylander, E. & Wadell, G. (1992). Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. Journal of Clinical Microbiology 30, 987-992.
16. Evander, M., Edlund, K., Gustafsson, A., Jonsson, M., Karlsson, R., Rylander, E. & Wadell, G. (1995). Human papillomavirus infection is transient in young women: a population-based cohort study. Journal of Infectious Diseases 171, 1026-1030.
17. Franco, E. L. (1991). The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology 2, 98-106.
18. Hakama, M., Lehtinen, M., Knekt, P., Aromaa, A., Leinikki, P., Miettinen, A., Paavonen, J., Peto, R. & Teppo, L. (1993). Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. American Journal of Epidemiology 137, 166-170.
19. Heino, P., Skyldberg, B., Lehtinen, M., Rantala, I., Hagmar, B., Kreider, J. W., Kirnbauer, R. & Dillner, J. (1995). Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes. Journal of General Virology 76, 1141-1153.
20. Hildesheim, A., Mann, V., Brinton, L. A., Szklo, M., Reeves, W. C. & Rawls, W. E. (1993). Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 and the development of invasive cervical cancer. American Journal of Epidemiology 137, 166-170.
21. Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P. & Sherman, M. E. (1994). Persistence of type-specific human papillomavirus infection among cytologically normal women. Journal of Infectious Diseases 169, 235-240.
22. Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J. & Burk, R. D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine 338, 423-428.
23. Kirnbauer, R., Hubbert, N. L., Wheeler, C. M., Becker, T. M., Lowy, D. R. & Schiller, J. T. (1994). A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. Journal of the National Cancer Institute 86, 4904-4909.
24. Kjellberg, L., Wiklund, F., Sjöberg, I., Wadell, G., Ångström, T., Dillner, J. & Mählck, C. G. (1998). A population-based study of HPV DNA testing for predicting cervical intraepithelial neoplasia. American Journal of Obstetrics and Gynecology (in press).
25. Koss, L. G. (editor) (1979). Diagnostic Cytology and its Histologic Basis, 3rd edn. Philadelphia: Lippincott.
26. Manos, M. M., Ting, Y., Wright, D. K., Lewis, A. J., Broker, T. R. & Wollinsky, S. M. (1989). Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 7, 209-214.
27. Melkert, P. W., Hopman, E., Van Den Brule, A. J., Risse, E. K., Van Diest, P. J., Bleker, O. P., Helmerhorst, T., Schipper, M. E., Meijer, C. J. & Walboomers, J. M. (1993). Prevalence of HPV in cytomorphologically normal smears, as determined by the polymerase chain reaction, is age-dependent. International Journal of Cancer 53, 919-923.
28. Munoz, N., Bosch, F. X., de Sanjosé, S., Vergara, A., del Moral, A., Munoz, M. T., Tafur, L., Gili, M., Izarzugaza, I., Viladiu, P. and 7 others (1993). Risk factors for cervical intraepithelial neoplasia grade III/ carcinoma in situ in Spain and Colombia. Cancer Epidemiology, Biomarkers and Prevention 2, 423-431.
29. Olsen, A. O., Dillner, J., Gjoen, K. & Magnus, P. (1997). Seropositivity against HPV 16 capsids: a better marker of past sexual behavior than presence of HPV DNA. Genitourinary Medicine 73, 131-135.
30. Parkin, D. M., Laara, E. & Muir, C. S. (1988). Estimates of the worldwide frequency of 16 major cancers in 1980. International Journal of Cancer 41, 184-197.
31. Schiffman, M. H. (1995). Epidemiology of human papillomaviruses. Dermatology Clinics 13, 561-574.
32. Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., Stanton, C. K. & Manos, M. M. (1993). Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. Journal of the National Cancer Institute 85, 958-964.
33. Slattery, M. L., Overall, J. C., Abbott, T. M., French, T. K., Robinson, L. M. & Gardner, J. (1989). Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. American Journal of Epidemiology 130, 248-258.
34. Snijders, P. J. F., van den Brute, A. J. C., Schrijnemakers, H. F. J., Snow, G., Meijer, C. J. L. M. & Walboomers, J. M. M. (1990). The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. Journal of General Virology 71, 173-181.
35. Stone, K., Zaidi, A., Rosero-Bixby, L., Oberle, M. W., Reynolds, G., Larsen, S., Nahmias, A. J., Lee, F., Schachter, J. & Guinan, M. E. (1995). Sexual behaviour, sexually transmitted diseases, and risk of cervical cancer. Epidemiology 6, 409-414.
36. Strickler, H. D., Schiffman, M. H., Eklund, C., Glass, A. G., Scott, D. R., Sherman, M. E., Wacholder, S., Kurman, R. J., Manos, M. M., Schiller, J. T. & Dillner, J. (1997). Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions. Cancer Epidemiology, Biomarkers and Prevention 6, 183-188.
37. Wideroff, L., Schiffman, M. H., Nonnenmacher, B., Hubbert, N., Kirnbauer, R., Greer, C. E., Lowy, D., Lorincz, A. T., Manos, M. M., Glass, A. G., Scott, D. R., Sherman, M. E., Kurman, R. J., Buckland, J., Tarone, R. E. & Schiller, J. (1995). Evaluation of seroreactivity to human papillomavirus type 16 virus-like particle in an incident case-control study of cervical neoplasia. Journal of Infectious Diseases 172, 1425-1430.
38. Wideroff, L., Schiffman, M. H., Hoover, R., Tarone, R. E., Nonnenmacher, B., Hubbert, N., Kirnbauer, R., Greer, C. E., Lorincz, A. T., Manos, M. M., Glass, A. G., Scott, D. R., Sherman, M. E., Buckland, J., Lowy, D. & Schiller, J. (1996). Epidemiologic determinants of seroreactivity to human papillomavirus type 16 virus-like particles in cervical HPV 16 DNA-positive and negative women. Journal of Infectious Diseases 174, 937-943.
39. Wikström, A., van Doornum, G. J. J., Quint, W. G. V., Schiller, J. T. & Dillner, J. (1995). Identification of human papillomavirus seroconversions. Journal of General Virology 76, 529-539.
40. Viscidi, R. P., Kotloff, K. L., Clayman, B., Russ, K., Shapiro, S. & Shah, K. V. (1997). Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clinical and Diagnostic Laboratory Immunology 4, 122-126.
41. Yap, E., Ho, T. H., Chan, Y. C., Thong, T. W., Ng, G. C., Ho, L. C. & Singh, M. (1995). Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients. Genitourinary Medicine 71, 402-404.